United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources & ProQuest (Firm). (1998). FDA oversight: Blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and ProQuest (Firm). FDA Oversight: Blood Safety and the Implications of Pool Sizes in the Manufacture of Plasma Derivatives : Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, First Session, July 31, 1997. Washington: U.S. G.P.O., 1998.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and ProQuest (Firm). FDA Oversight: Blood Safety and the Implications of Pool Sizes in the Manufacture of Plasma Derivatives : Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, First Session, July 31, 1997. U.S. G.P.O., 1998.